FastSaying

Bristol-Myers' dividend has been an important attraction for value minded investors -- providing the key back-stop for shares even amidst the company's near-term negative growth outlook and lackluster pipeline news.

Related Quotes

Investors are becoming cautious after shares have performed so well.
— Michael Fraikin
BecomingCautiousInvestors
Too many investors tend to be backward looking. You can't just say they declared the quarterly dividend for the last 10 years, I guess they're going to keep paying it. Think about what the business conditions are.
— Don Cassidy
BackwardDeclaredDividend
The diabetes market appears poised to post accelerating growth over the coming years.
— Chris Shibutani
AcceleratingAppearsComing
With Pfizer's diversified product portfolio and cash position that can be used for future deals, we would expect the company to be able to absorb the financial impact.
— Chris Shibutani
CashCompanyDeals
With Pfizer's diversified product portfolio and cash position that can be used for future deals, we would expect the company to be able to absorb the financial impact,
— Chris Shibutani
CashCompanyDeals